Sorrento Therapeutics, Inc. (SRNE)

OTC Markets OTCPK • Currently up 0.00 (+33.33%) in today's trading session

Track congressional stock trades in Sorrento Therapeutics, Inc. (SRNE). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Sorrento Therapeutics, Inc. is currently trading at $0.00, positioned at 3% of its 52-week range ($0.00 – $0.01).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$0.00
24h Change
+0.00 (+33.33%)
52 Week Range
$0.00–$0.01
View on NASDAQ

Sorrento Therapeutics, Inc. Price History and Technical Analysis

Congressional Trading Activity for SRNE

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$220.51K

Volume

501.68K

Beta

0.13

P/E Ratio

-0.01

Fundamentals

EPS

$-0.05

Div. Yield

-

Open

$0.00

Day Range

$0.00 – $0.01

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
OTC · USD
Country
US
CEO
Henry H. Ji
IPO Date
2007-01-19

Sorrento Therapeutics, Inc. is a biopharmaceutical company, active in both clinical development and commercial operations, dedicated to creating treatments for a range of serious conditions including cancer, autoimmune disorders, inflammatory disease...

Earnings

Next Report

Q3 2026

23 Nov

EPS Est.

$0.42

Rev. Est.

$18.2M

Days Until

1

Recent Quarters

Q3 202620 Nov
EPS-
Q3 202619 Nov
EPS-
Q3 202618 Nov
EPS-
Q3 202617 Nov
EPS-
Q3 202616 Nov
EPS-
Q3 202613 Nov
EPS-
Q3 202612 Nov
EPS-
Q3 202611 Nov
EPS-
Q3 202610 Nov
EPS-
Q3 20266 Nov
EPS-
Q2 202628 Aug
EPS-
Q1 202629 May
EPS-
Q4 202525 Feb
EPS-
Q4 202411 Feb
EPS-
Q3 202427 Dec
EPS-
Q3 20241 Nov
EPS-
Q1 202410 Jun
EPS-
Q4 202328 Feb
EPS-
Q3 20233 Nov
EPS-
Q2 202312 Aug
EPS$-0.17
Miss 15.1%
Q1 202315 May
EPS$-0.26
Miss 60.7%
Q4 202215 Mar
EPS$-0.34
Miss 79.8%
Q3 20228 Nov
EPS$-0.20
Beat 20.0%
Q2 202215 Aug
EPS$-0.54
Miss 134.8%
Q1 20225 May
EPS$-0.12
Beat 52.0%
Q4 202111 Mar
EPS$-0.47
Miss 62.1%
Q3 20215 Nov
EPS$-0.40
Miss 90.5%
Q2 20216 Aug
EPS$-0.33
Miss 65.0%
Q1 20215 May
EPS$0.01
Miss 97.4%
Q4 202019 Feb
EPS$-0.27
Miss 17.4%
Q3 20206 Nov
EPS$-0.33
Miss 32.0%
Q2 20204 Aug
EPS$-0.22
Beat 8.3%
Q1 202011 May
EPS$-0.26
Miss 30.0%
Q4 20192 Mar
EPS$-0.41
Beat 0.0%
Q3 20198 Nov
EPS$-0.42
Beat 0.0%
Q2 20199 Aug
EPS$-0.39
Beat 2.5%
Q1 201915 May
EPS$-0.30
Beat 14.3%
Q4 201815 Mar
EPS$-0.40
Miss 48.1%
Q3 20189 Nov
EPS$-0.40
Miss 110.5%
Q2 20189 Aug
EPS$-0.73
Miss 265.0%
Q1 201810 May
EPS$-0.38
Miss 137.5%
Q4 201716 Mar
EPS$0.72
Beat 614.3%
Q3 20179 Nov
EPS$0.44
Beat 291.3%
Q2 20179 Aug
EPS$-0.20
Beat 41.2%
Q1 201715 May
EPS$-0.45
Miss 36.4%
Q4 201621 Mar
EPS$-0.44
Miss 63.0%
Q3 20169 Nov
EPS$-0.19
Beat 9.5%
Q2 20168 Aug
EPS$-0.28
Miss 64.7%
Q1 201610 May
EPS$-0.63
Miss 70.3%
Q4 201515 Mar
EPS$-0.63
Beat 32.3%
Q3 201516 Nov
EPS$-0.82
Miss 121.6%
Q2 20157 Aug
EPS$-0.30
Beat 6.3%
Q1 20155 May
EPS$-0.29
Miss 107.1%
Q4 201413 Mar
EPS$-0.28
Miss 3.7%
Q3 20144 Nov
EPS$-0.27
Beat 20.6%
Q2 20146 Aug
EPS$-0.33
Beat 2.9%
Q1 201414 May
EPS$-0.44
Miss 51.7%
Q1 20141 Apr
EPS$-0.66
Miss 288.2%
Q3 201314 Nov
EPS$-0.23
Miss 21.1%
Q1 201315 May
EPS$-0.20
Q4 201225 Mar
EPS$-0.14
Q3 20128 Nov
EPS$-0.10
Q2 201214 Aug
EPS$-0.08
Q1 201215 May
EPS$-0.09
Q4 201130 Mar
EPS$-0.07
Q3 20118 Nov
EPS$-0.07
Q2 201112 Aug
EPS$-0.11
Q1 201111 May
EPS$-0.07
Q4 201018 Mar
EPS$-0.02
Q3 20108 Nov
EPS$-0.05
Q2 201012 Aug
EPS$-0.07
Q1 201014 May
EPS$-0.07
Q4 200925 Mar
EPS$-0.08
Q3 200912 Nov
EPS$-0.03
Q2 200913 Aug
EPS$-0.18
Q1 200913 May
EPS$-0.13
Q4 200830 Mar
EPS$-0.10
Q3 200813 Nov
EPS$-2.89
Q2 200814 Aug
EPS$-0.02
Q1 200814 May
EPS$-0.04
Q4 200731 Mar
EPS$-0.02
Q3 20077 Nov
EPS$-0.03
Q2 200713 Aug
EPS$-0.04
Q1 200714 May
EPS$-3.12
Q4 200619 Mar
EPS$-3.87
Q2 200614 Aug
EPS$-0.01

No dividend data available for this stock.

Stock Splits

Split History

1 Aug 2013Reverse Split
Ratio1:25
7 Oct 2008Reverse Split
Ratio1:10
16 Mar 2007Reverse Split
Ratio1:20

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.